Skip to main content
. 2017 Oct 19;21:252. doi: 10.1186/s13054-017-1849-0

Fig. 2.

Fig. 2

Forest plot depicting analysis of the risk for postoperative renal replacement therapy in patients treated with levosimendan vs placebo. LVEF Left ventricular ejection fraction, LCOS Low cardiac output syndrome, M-H Mantel-Haenszel